Establishment and Characterization of Patient-Derived Xenograft Model of Non-Small-Cell Lung Cancer Derived from Malignant Pleural Effusions

References

• Chen W, Sun K, Zheng R, et al. Cancer incidence and mortality in China, 2014. Chin J Cancer Res. 2018;30(1):1–12. doi:10.21147/j.issn.1000-9604.2018.01.01
   PubMed Web of Science ®Google Scholar
• Chen Z, Fillmore CM, Hammerman PS, et al. Non-small-cell lung cancers: a heterogeneous set of diseases. Nat Rev Cancer. 2014;14(8):535–546. doi:10.1038/nrc3775
   PubMed Web of Science ®Google Scholar
• Hoffman PC, Mauer AM, Vokes EE. Lung cancer. Lancet. 2000;355(9202):479–485. doi:10.1016/S0140-6736(00)82038-3
   PubMed Web of Science ®Google Scholar
• Ettinger DS, Akerley W, Borghaei H, et al. National comprehensive cancer network. Non-small cell lung cancer, version 2.2013. J Natl Compr Canc Netw. 2013;11(6):645–53;quiz 653. doi:10.6004/jnccn.2013.0084
   PubMed Web of Science ®Google Scholar
• Morgensztern D, Waqar S, Subramanian J, et al. Prognostic impact of malignant pleural effusion at presentation in patients with metastatic non-small-cell lung cancer. J Thorac Oncol. 2012;7(10):1485–1489. doi:10.1097/JTO.0b013e318267223a
   PubMed Web of Science ®Google Scholar
• Taghizadeh N, Fortin M, Tremblay A. US hospitalizations for malignant pleural effusions: data from the 2012 national inpatient sample. Chest. 2017;151(4):845–854. doi:10.1016/j.chest.2016.11.010
   PubMed Web of Science ®Google Scholar
• Yeh CT, Wu AT, Chang PM, et al. Trifluoperazine, an antipsychotic agent, inhibits cancer stem cell growth and overcomes drug resistance of lung cancer. Am J Respir Crit Care Med. 2012;186(11):1180–1188. doi:10.1164/rccm.201207-1180OC
   PubMed Web of Science ®Google Scholar
• Huisman C, Smit EF, Giaccone G, Postmus PE. Second-line chemotherapy in relapsing or refractory non-small-cell lung cancer: a review. J Clin Oncol. 2000;18(21):3722–3730. doi:10.1200/JCO.2000.18.21.3722
   PubMed Web of Science ®Google Scholar
• Gao H, Korn JM, Ferretti S, et al. High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response. Nat Med. 2015;21(11):1318–1325. doi:10.1038/nm.3954
   PubMed Web of Science ®Google Scholar
• Byrne AT, Alférez DG, Amant F, et al. Interrogating open issues in cancer precision medicine with patient-derived xenografts. Nat Rev Cancer. 2017;17(4):254–268. doi:10.1038/nrc.2016.140
   PubMed Web of Science ®Google Scholar
• Kim HR, Kang HN, Shim HS, et al. Co-clinical trials demonstrate predictive biomarkers for dovitinib, an FGFR inhibitor, in lung squamous cell carcinoma. Ann Oncol. 2017;28(6):1250–1259. doi:10.1093/annonc/mdx098
   PubMed Web of Science ®Google Scholar
• Chen Y, Chen HN, Wang K, et al. Ketoconazole exacerbates mitophagy to induce apoptosis by downregulating cyclooxygenase-2 in hepatocellular carcinoma. J Hepatol. 2019;70(1):66–77. doi:10.1016/j.jhep.2018.09.022
   PubMed Web of Science ®Google Scholar
• Fong EL, Wan X, Yang J, et al. A 3D in vitro model of patient-derived prostate cancer xenograft for controlled interrogation of in vivo tumor-stromal interactions. Biomaterials. 2016;77:164–172. doi:10.1016/j.biomaterials.2015.10.059
   PubMed Web of Science ®Google Scholar
• Wang H, Zhou L, Xie K, et al. Polylactide-tethered prodrugs in polymeric nanoparticles as reliable nanomedicines for the efficient eradication of patient-derived hepatocellular carcinoma. Theranostics. 2018;8(14):3949–3963. doi:10.7150/thno.26161
   PubMed Web of Science ®Google Scholar
• Ilie M, Nunes M, Blot L, et al. Setting up a wide panel of patient-derived tumor xenografts of non-small cell lung cancer by improving the preanalytical steps. Cancer Med. 2015;4(2):201–211. doi:10.1002/cam4.357
   PubMed Web of Science ®Google Scholar
• Stein AP, Saha S, Liu CZ, et al. Influence of handling conditions on the establishment and propagation of head and neck cancer patient derived xenografts. PLoS One. 2014;9(6):e100995. doi:10.1371/journal.pone.0100995
   PubMed Web of Science ®Google Scholar
• Roscilli G, De Vitis C, Ferrara FF, et al. Human lung adenocarcinoma cell cultures derived from malignant pleural effusions as model system to predict patients chemosensitivity. J Transl Med. 2016;14:61. doi:10.1186/s12967-016-0816-x
   PubMed Web of Science ®Google Scholar
• Fujii E, Kato A, Chen YJ, et al. The status of donor cancer tissues affects the fate of patient-derived colorectal cancer xenografts in NOG mice. Exp Anim. 2015;64(2):181–190. doi:10.1538/expanim.14-0080
   PubMed Web of Science ®Google Scholar
• Mancini R, Giarnieri E, De Vitis C, et al. Spheres derived from lung adenocarcinoma pleural effusions: molecular characterization and tumor engraftment. PLoS One. 2011;6(7):e21320. doi:10.1371/journal.pone.0021320
   PubMed Web of Science ®Google Scholar
• Grimshaw MJ, Cooper L, Papazisis K, et al. Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells. Breast Cancer Res. 2008;10(3):R52. doi:10.1186/bcr2106
   PubMed Web of Science ®Google Scholar
• Basak SK, Veena MS, Oh S, et al. The malignant pleural effusion as a model to investigate intratumoral heterogeneity in lung cancer. PLoS One. 2009;4(6):e5884. doi:10.1371/journal.pone.0005884
   PubMed Web of Science ®Google Scholar
• Klinghammer K, Walther W, Hoffmann J. Choosing wisely - preclinical test models in the era of precision medicine. Cancer Treat Rev. 2017;55:36–45. doi:10.1016/j.ctrv.2017.02.009
   PubMed Web of Science ®Google Scholar
• Wakefield CE, Doolan EL, Fardell JE, et al. The avatar acceptability study: survivor, parent and community willingness to use patient-derived xenografts to personalize cancer care. EBioMedicine. 2018;37:205–213. doi:10.1016/j.ebiom.2018.10.060
   PubMed Web of Science ®Google Scholar
• Heinrich MA, Mostafa AMRH, Morton JP, et al. Translating complexity and heterogeneity of pancreatic tumor: 3D in vitro to in vivo models. Adv Drug Deliv Rev. 2021;174:265–293. doi:10.1016/j.addr.2021.04.018
   PubMed Web of Science ®Google Scholar
• Park B, Jeong BC, Choi YL, et al. Development and characterization of a bladder cancer xenograft model using patient-derived tumor tissue. Cancer Sci. 2013;104(5):631–638. doi:10.1111/cas.12123
   PubMed Web of Science ®Google Scholar
• Xin Y, Li S, Jiang Q, et al. Establishment of a jaw fibrosarcoma patient-derived xenograft and evaluation of the tumor suppression efficacy of plumbagin against jaw fibrosarcoma. Front Oncol. 2020;10:1479. doi:10.3389/fonc.2020.01479
   PubMed Web of Science ®Google Scholar
• Chen X, Shen C, Wei Z, et al. Patient-derived non-small cell lung cancer xenograft mirrors complex tumor heterogeneity. Cancer Biol Med. 2021;18(1):184–198. doi:10.20892/j.issn.2095-3941.2020.0012
   PubMed Web of Science ®Google Scholar